The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-((4-(4-Chloro-3-(trifluoromethyl)phenoxy)-3,5-difluorobenzyl)-oxy)-6-(4-cyclopropylpiperazin-1-yl)-1-methylpyrimidin-2(1H)-one ID: ALA3792761
Chembl Id: CHEMBL3792761
PubChem CID: 121448433
Max Phase: Preclinical
Molecular Formula: C26H24ClF5N4O3
Molecular Weight: 570.95
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cn1c(N2CCN(C3CC3)CC2)cc(OCc2cc(F)c(Oc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)nc1=O
Standard InChI: InChI=1S/C26H24ClF5N4O3/c1-34-23(36-8-6-35(7-9-36)16-2-3-16)13-22(33-25(34)37)38-14-15-10-20(28)24(21(29)11-15)39-17-4-5-19(27)18(12-17)26(30,31)32/h4-5,10-13,16H,2-3,6-9,14H2,1H3
Standard InChI Key: QOWHDNHDLZYUKL-UHFFFAOYSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 570.95Molecular Weight (Monoisotopic): 570.1457AlogP: 5.39#Rotatable Bonds: 7Polar Surface Area: 59.83Molecular Species: NEUTRALHBA: 7HBD: 0#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 0#RO5 Violations (Lipinski): 2CX Acidic pKa: CX Basic pKa: 7.44CX LogP: 5.47CX LogD: 5.15Aromatic Rings: 3Heavy Atoms: 39QED Weighted: 0.36Np Likeness Score: -1.23
References 1. Chen X, Wang K, Xu W, Ma Q, Chen M, Du L, Mo M, Wang Y, Shen J.. (2016) Discovery of Potent and Orally Active Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Inhibitors as a Potential Therapy for Diabetic Macular Edema., 59 (6): [PMID:26927682 ] [10.1021/acs.jmedchem.5b01930 ]